In Defense of Off-label Prescribing.

JAMA Intern Med

Independent Internist, Lomita, California.

Published: June 2016

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamainternmed.2016.1403DOI Listing

Publication Analysis

Top Keywords

defense off-label
4
off-label prescribing
4
defense
1
prescribing
1

Similar Publications

Article Synopsis
  • - The study aimed to evaluate a closed-loop resuscitation algorithm called ReFit1 and ReFit2, which uses various hemodynamic parameters to effectively manage severe hemorrhagic shock in a pig model.
  • - The ReFit algorithm determines the need for fluids and medications based on real-time monitoring of vital signs, such as mean arterial pressure and mixed venous oxygen saturation, to drive automated treatments.
  • - Results showed that the time to stabilize the pigs using these algorithms was comparable to traditional methods used by expert clinicians, with similar treatment volumes, and ReFit1 also successfully addressed complications like acute air embolism in some animals.
View Article and Find Full Text PDF
Article Synopsis
  • Anti-IL-1 biologics, particularly anakinra, are being explored for treating autoimmune and autoinflammatory conditions in children, highlighting their off-label use.
  • Anakinra has shown effectiveness in personalized treatment approaches and for conditions like rheumatic fever and post-viral arthritis, while canakinumab has been linked to long-term remission.
  • The authors call for increased collaboration to enhance access to these medications, aiming to better manage harmful inflammation in pediatric patients.
View Article and Find Full Text PDF
Article Synopsis
  • The study evaluates the effectiveness of a new thrombus removal method called Contact Aspiration Mechanical Thrombectomy (CAMT) using specialized catheters (FreeClimb 88 and Tenzing 8) in treating large vessel occlusions in the brain.
  • A retrospective analysis of 53 patients showed a high success rate for delivering the FreeClimb 88 catheter to the occlusion site, with 94.3% successful deliveries and a first-pass success rate of 67.9% for restoring blood flow.
  • The procedure was found to be safe, with no complications or symptomatic hemorrhages, indicating that this technique could be a reliable option for treating these severe blockages.
View Article and Find Full Text PDF

Aflatoxin M (AFM), a hydroxylated metabolite of aflatoxin B (AFB), contaminates milk and dairy products from livestock ingestion of feed contaminated with a species of . As AFM is a Group-II B carcinogen, it is indispensable to develop novel, easy-to-handle, sensitive, portable and cost-effective strategies for its detection. Herein, a covalent organic framework (COF)-based electroactive nanocomposite, AgO/g-CN-COOH@MA-DBB-COF (silver oxide/carboxy-functionalized graphitic carbon nitride@melamine-dibromo butane COF), is designed to serve as a multifunctional receptor surface.

View Article and Find Full Text PDF

Background: Women with breast cancer face many barriers to return to work (RTW) after their cancer. The main objective of the FASTRACS-RCT is to evaluate the impact of the FASTRACS (Facilitate and Sustain Return to Work after Breast Cancer) intervention on the sustainable RTW of breast cancer patients, 12 months after the end of active treatment.

Methods: FASTRACS-RCT is a prospective, national, multicentre, randomized, controlled and open-label study.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!